EcoDrugPlus

Ensembl ID : ENSOJAG00000014945
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOJAG00000015799
Gene Symbol: -
Cross references: -
404 Possible Orthologues:

Ensembl ID : ENSOJAG00000015775
Gene Symbol: -
Cross references: -
401 Possible Orthologues:

Ensembl ID : ENSOJAG00000015701
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSOJAG00000023286
Gene Symbol: SIGMAR1
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSOJAG00000009641
Gene Symbol: RPL19
1 Cross references
319 Possible Orthologues:

Ensembl ID : ENSOJAG00000011224
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOJAG00000007064
Gene Symbol: -
Cross references: -
969 Possible Orthologues:

Ensembl ID : ENSOJAG00000016361
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOJAG00000006189
Gene Symbol: SLC22A6L
1 Cross references
358 Possible Orthologues:

Ensembl ID : ENSOJAG00000004786
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOJAG00000013985
Gene Symbol: -
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).